查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医用聚合物的全球市场：按类型、应用、製造技术和地区划分 – 预测（至 2029 年）
市场调查报告书
商品编码
1479078

医用聚合物的全球市场：按类型、应用、製造技术和地区划分 – 预测（至 2029 年）

Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments And Devices, Prosthetics, Diagnostics Instruments And Tools), Manufacturing Technology, and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 427 Pages | 订单完成后即时交付

价格
简介目录

全球医用聚合物市场规模预计将从 2024 年的 4,110 万美元增至 2029 年的 6,050 万美元，预测期内复合年增长率为 8.0%。

由于人们对医疗保健品质和安全的日益关注，对医用聚合物的需求不断增加，从而促进了创新医疗设备和设备的发展。此外，聚合物技术的进步正在扩大医用聚合物的功能和应用，促进其在各个医疗领域的采用。这种不断增长的需求也推动了对医疗环境中生物相容、耐用且易于消毒的材料的需求。

调查范围
调查年份 2020-2029
基准年 2023年
预测期 2024-2029
单元 金额（百万美元）、数量（千吨）
部分 类型、用途、製造技术、地区
目标区域 亚太地区、北美、欧洲、中东/非洲、南美

“按以金额为准，医用合成橡胶在细分市场中占据第二大市场份额。”

医用合成橡胶由于其独特的性能和在医疗应用中的多功能性，在医用聚合物领域占据第二大市场占有率。这些合成橡胶具有弹性、弹性和生物相容性等特性，非常适合用于需要弹性和耐用性的医疗设备和组件，例如导管、密封和手术手套。对医用合成橡胶的需求也受到其承受灭菌过程和医疗环境中常见的恶劣化学环境的能力的推动。此外，合成橡胶配方和加工技术开发的进步导致性能提高和应用范围扩大，有助于合成橡胶在医用聚合物产业中占据重要的市场影响。

“按以金额为准，一次性医疗用品在应用领域占据第二大市场份额。”

由于多重因素的影响，一次性医疗用品在市场应用领域占据第二大市场占有率。首先，对感染控制和病人安全的日益担忧正在推动对一次性医疗用品的需求，例如由医用聚合物製成的注射器、手套和外科用覆盖巾。这些一次性用品方便、无菌，并降低了交叉污染的风险，使其在医疗环境中至关重要。由于门诊病人和居家医疗的增加，一次性医疗用品的消耗量也在增加。此外，聚合物技术的进步使得经济高效且环保的一次性医疗产品的开发成为可能，进一步促进了它们的采用并为其巨大的市场占有率做出了贡献。

“按以金额为准，射出成型在市场製造技术领域占据第二大份额。”

射出成型因其效率、精度和多功能性而在市场製造技术领域以金额为准第二大份额。该技术能够大量生产复杂的客製化医疗零件，并具有一致的品质和尺寸精度。射出成型成型医疗设备和产品，例如注射器、静脉注射导管和植入式器械，可以利用生物相容性、无菌性和耐用性等特性。此外，射出成型深受医疗设备製造商的欢迎，因为它可以实现经济高效的生产、缩短前置作业时间并减少材料浪费。此外，射出成型技术的进步，包括自动化和数数位化，进一步提高了医用聚合物产业射出成型的能力和市场竞争力。

本报告研究和分析了全球医用聚合物市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • 医用聚合物市场对公司有吸引力的机会
  • 医用聚合物市场：依类型
  • 医用聚合物市场：依应用分类
  • 医用聚合物市场：依製造技术分类
  • 医用聚合物市场：依国家分类

第五章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 波特五力分析
  • 总体经济指标

第六章 产业趋势

  • 介绍
  • 主要相关利益者和采购标准
  • 价值链分析
    • 原料
    • 製作者
    • 分配
    • 最终用户
  • 生态系分析
  • 案例研究分析
  • 监管环境
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 影响客户业务的趋势/干扰
  • 贸易分析
    • 导入场景
    • 出口场景
  • 重大会议及活动
  • 价格分析
    • 平均销售价格趋势：按地区
    • 平均销售价格趋势：依用途
    • 主要企业平均售价趋势：依用途
  • 投资金筹措场景
  • 专利分析

第七章医用聚合物市场：依类型

  • 介绍
  • 医用塑料
  • 医用合成橡胶

第八章医用聚合物市场：依製造技术分类

  • 介绍
  • 管材挤出
  • 压缩成型
  • 射出成型
  • 其他製造技术

第九章医用聚合物市场：依应用分类

  • 介绍
  • 医疗一次性用品
  • 医疗设备
  • 义肢
  • 诊断设备
  • 其他用途

第十章医用聚合物市场：依地区

  • 介绍
  • 北美洲
    • 经济衰退对北美的影响
    • 美国
    • 加拿大
    • 墨西哥
  • 亚太地区
    • 景气衰退的影响
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 其他亚太地区
  • 欧洲
    • 景气衰退的影响
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 中东/非洲
    • 景气衰退的影响
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东/非洲
  • 南美洲
    • 景气衰退的影响
    • 巴西
    • 阿根廷
    • 南美洲其他地区

第十一章竞争格局

  • 概述
  • 主要企业策略
  • 市场占有率分析
  • 收益分析
  • 公司评价及财务指标
  • 品牌/产品比较
  • 企业评价矩阵：主要企业（2023年）
  • 企业评价矩阵：Start-Ups、中小企业
  • 竞争格局及趋势

第十二章 公司简介

  • 主要企业
    • BASF SE
    • SABIC
    • COVESTRO AG
    • CELANESE CORPORATION
    • EVONIK INDUSTRIES
    • ARKEMA
    • SOLVAY
    • KURARAY CO., LTD.
    • MOMENTIVE PERFORMANCE MATERIALS INC.
    • DUPONT
  • 其他公司
    • TRINSEO
    • KRATON CORPORATION
    • TOTAL PLASTICS
    • SIMONA AMERICA
    • DSM
    • INVIBIO
    • AVIENT CORPORATION
    • RTP COMPANY
    • TEKNIPLEX
    • TEKNOR APEX
    • MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • WACKER CHIMIE
    • HARDIE POLYMERS
    • ELIX POLYMERS
    • INNOVATIVE POLYMER COMPOUNDS

第十三章附录

简介目录
Product Code: CH 9017

The global medical polymer market is expected to grow at a CAGR of 8.0% during the forecast period, from an estimated USD 41.1 million in 2024 to USD 60.5 million by 2029. The demand for medical polymers is increasing due to the growing emphasis on healthcare quality and safety, leading to the development of innovative medical devices and equipment. Additionally, advancements in polymer technology have expanded the capabilities and applications of medical polymers, driving their adoption across various medical fields. This rising demand is also fueled by the need for materials that offer biocompatibility, durability, and ease of sterilization in medical settings.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million), Volume (Kiloton)
SegmentsType, Application, Manufacturing Technology, and Region
Regions coveredAsia Pacific, North America, Europe, Middle East & Africa, and South America

"Medical elastomers accounted for the second largest share in type segment of medical polymer market in terms of value."

Medical elastomers hold the second-largest market share in the medical polymer segment due to their unique properties and versatility in medical applications. These elastomers offer characteristics such as flexibility, resilience, and biocompatibility, making them ideal for use in medical devices and components that require elasticity and durability, such as catheters, seals, and surgical gloves. The demand for medical elastomers is also driven by their ability to withstand sterilization processes and harsh chemical environments commonly found in healthcare settings. Furthermore, ongoing developments in elastomer formulations and processing techniques continue to enhance their performance and expand their applications, contributing to their significant market presence in the medical polymer industry.

"Medical disposables accounted for the second largest share in application segment of medical polymer market in terms of value."

Medical disposables hold the second-largest market share in the application segment of the medical polymer market due to several key factors. Firstly, the increasing focus on infection control and patient safety has driven the demand for single-use medical products, such as syringes, gloves, and surgical drapes, made from medical polymers. These disposables offer convenience, sterility, and reduced risk of cross-contamination, making them essential in healthcare settings. Additionally, the rise in outpatient and home-based care has led to higher consumption of disposable medical supplies. Moreover, advancements in polymer technology have enabled the development of cost-effective and environmentally friendly disposable medical products, further fueling their adoption and contributing to their significant market share.

"Injection molding accounted for the second largest share in the manufacturing technology segment of medical polymer market in terms of value."

Injection molding holds the second-largest market share in the manufacturing technology segment of the medical polymer market due to its efficiency, precision, and versatility. This technology allows for the mass production of intricate and customized medical components with consistent quality and dimensional accuracy. Medical devices and products manufactured through injection molding, such as syringes, IV catheters, and implantable devices, benefit from properties like biocompatibility, sterilizability, and durability. Additionally, injection molding offers cost-effective production, shorter lead times, and reduced material wastage, making it highly favored by medical device manufacturers. Moreover, ongoing advancements in injection molding technology, including automation and digitalization, further enhance its capabilities and market competitiveness in the medical polymer industry.

"Europe is the second-largest market for medical polymer."

Europe holds the second-largest market share globally in the medical polymer market due to several key factors. Firstly, the region benefits from a well-established healthcare infrastructure, advanced research and development capabilities, and stringent regulatory standards, fostering innovation and quality in medical polymer products. Additionally, the increasing aging population and prevalence of chronic diseases drive the demand for advanced medical devices and equipment, which rely heavily on medical polymers. Moreover, Europe's strong emphasis on healthcare modernization, sustainability, and patient safety further propels the adoption of medical polymers. Furthermore, strategic collaborations between industry players, research institutions, and healthcare providers contribute to the region's leadership in the global medical polymer market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the medical polymer market, and information was gathered from secondary research to determine and verify the market size of several segments.

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C Level Executives- 20%, Directors - 10%, and Others - 70%
  • By Region: North America - 20%, Europe - 20%, APAC - 40%, South America- 10% , and

the Middle East & Africa -10%

The medical polymer market comprises major players such as BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), DuPont (US), and others. The study includes in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This report segments the market for medical polymer market on the basis of type, application, manufacturing technology, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, new product launches, expansions, and mergers & acquisition associated with the market for medical polymer market.

Key benefits of buying this report

This research report is focused on various levels of analysis - industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view on the competitive landscape; emerging and high-growth segments of the medical polymer market; high-growth regions; and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the medical polymer market offered by top players in the global medical polymer market.
  • Analysis of drivers: (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), and challenges (Cost constraints for novel materials, Long term durability and degradation control) influencing the growth of medical polymer market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical polymer market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for medical polymer market across regions.
  • Market Capacity: Production capacities of companies producing medical polymer are provided wherever available with upcoming capacities for the medical polymer market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical polymer market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS
  • 1.4 STUDY SCOPE
    • FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION
    • 1.4.1 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 UNITS CONSIDERED
  • 1.7 STAKEHOLDERS
  • 1.8 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of major secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary data sources: demand and supply sides
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 MARKET SIZE ESTIMATION APPROACH: DEMAND SIDE
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 MEDICAL POLYMER MARKET: DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • 2.5.1 SUPPLY SIDE
    • 2.5.2 DEMAND SIDE
  • 2.6 RESEARCH LIMITATION
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 7 MEDICAL PLASTICS SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD
    • FIGURE 8 MEDICAL INSTRUMENTS & DEVICES TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD
    • FIGURE 9 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET
    • FIGURE 10 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD
  • 4.2 MEDICAL POLYMER MARKET, BY TYPE
    • FIGURE 11 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD
  • 4.3 MEDICAL POLYMER MARKET, BY APPLICATION
    • FIGURE 12 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
    • FIGURE 13 EXTRUSION TUBING SEGMENT TO ACCOUNT FOR LARGEST SHARE OF MEDICAL POLYMER MARKET
  • 4.5 MEDICAL POLYMER MARKET, BY COUNTRY
    • FIGURE 14 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for biocompatible materials
      • 5.2.1.2 Growing aging population globally
      • 5.2.1.3 Advancements in medical technology
      • 5.2.1.4 Regulatory support for medical-grade materials
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory complexities and approvals
      • 5.2.2.2 High competition from alternative materials
      • 5.2.2.3 Environmental sustainability concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth in regenerative medicine
      • 5.2.3.2 Demand for minimally invasive devices
      • 5.2.3.3 Advancements in biodegradable polymers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Cost constraints for novel materials
      • 5.2.4.2 Long-term durability and degradation control
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 MEDICAL POLYMER MARKET: PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 16 PORTER'S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 MACROECONOMIC INDICATORS
    • 5.4.1 GLOBAL GDP TRENDS
    • TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018-2025

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
    • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
    • 6.2.2 BUYING CRITERIA
    • FIGURE 18 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
    • TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • 6.3 VALUE CHAIN ANALYSIS
    • FIGURE 19 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS
    • 6.3.1 RAW MATERIAL
    • 6.3.2 MANUFACTURER
    • 6.3.3 DISTRIBUTION
    • 6.3.4 END USER
  • 6.4 ECOSYSTEM ANALYSIS
    • FIGURE 20 MEDICAL POLYMER MARKET: ECOSYSTEM MAPPING
    • TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM
  • 6.5 CASE STUDY ANALYSIS
    • 6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
    • 6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
  • 6.6 REGULATORY LANDSCAPE
    • TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.7 TECHNOLOGY ANALYSIS
    • 6.7.1 KEY TECHNOLOGY
    • 6.7.2 COMPLEMENTARY TECHNOLOGY
    • 6.7.3 ADJACENT TECHNOLOGY
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • 6.8.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS
    • FIGURE 21 REVENUE SHIFT IN MEDICAL POLYMER MARKET
  • 6.9 TRADE ANALYSIS
    • 6.9.1 IMPORT SCENARIO
    • FIGURE 22 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019-2022 (USD THOUSAND)
    • 6.9.2 EXPORT SCENARIO
    • FIGURE 23 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019-2022 (USD THOUSAND)
  • 6.10 KEY CONFERENCES & EVENTS
    • TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2024-2025
  • 6.11 PRICING ANALYSIS
    • 6.11.1 AVERAGE SELLING PRICE TREND, BY REGION
    • FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION (USD/KILOTON)
    • 6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION
    • FIGURE 25 AVERAGE SELLING PRICE TREND, BY APPLICATION (USD/KILOTON)
    • 6.11.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
    • FIGURE 26 AVERAGE SELLING PRICE, BY KEY MARKET PLAYERS (USD/ KILOTON)
  • 6.12 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
  • 6.13 PATENT ANALYSIS
    • 6.13.1 METHODOLOGY
    • 6.13.2 PATENTS GRANTED WORLDWIDE, 2013-2023
    • TABLE 12 TOTAL NUMBER OF PATENTS
    • 6.13.3 PATENT PUBLICATION TRENDS
    • FIGURE 28 TOTAL NUMBER OF PATENTS PUBLISHED FROM 2013 TO 2023
    • 6.13.4 INSIGHTS
    • 6.13.5 LEGAL STATUS OF PATENTS
    • FIGURE 29 PATENT ANALYSIS, BY LEGAL STATUS
    • 6.13.6 JURISDICTION-WISE PATENT ANALYSIS
    • FIGURE 30 TOP JURISDICTIONS FOR MEDICAL POLYMER PATENTS
    • 6.13.7 TOP COMPANIES/APPLICANTS
    • FIGURE 31 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS
    • 6.13.8 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
    • TABLE 13 TOP TEN PATENT OWNERS

7 MEDICAL POLYMER MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • FIGURE 32 MEDICAL PLASTICS TO LEAD OVERALL MARKET DURING FORECAST PERIOD
    • TABLE 14 MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 15 MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
  • 7.2 MEDICAL PLASTICS
    • 7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
    • 7.2.2 POLYPROPYLENE (PP)
    • 7.2.3 POLYVINYL CHLORIDE (PVC)
    • 7.2.4 POLYETHYLENE (PE)
    • 7.2.5 POLYSTYRENE (PS)
    • 7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS
      • 7.2.6.1 Polyether ether ketone (PEEK)
      • 7.2.6.2 Nylon/polyamide (PA)
      • 7.2.6.3 Polyphenulsulfone (PPSU)
      • 7.2.6.4 Polysulfones (PSU)
      • 7.2.6.5 Polymethyl methacrylate (PMMA)
      • 7.2.6.6 Polycarbonate (PC)
      • 7.2.6.7 Acrylonitrile butadiene styrene (ABS)
      • 7.2.6.8 Other engineering & high-performance plastics
    • 7.2.7 OTHER MEDICAL PLASTICS
  • 7.3 MEDICAL ELASTOMERS
    • 7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
    • 7.3.2 SILICONE
    • 7.3.3 THERMOPLASTIC ELASTOMERS
      • 7.3.3.1 Thermoplastic polyurethane (TPU)
      • 7.3.3.2 Thermoplastic vulcanizates (TPV)
      • 7.3.3.3 Thermoplastic styrenic elastomers (TPS)
        • 7.3.3.3.1 Poly(styrene-butadiene-styrene) (SBS)
        • 7.3.3.3.2 Styrene-ethylene-butylene-styrene (SEBS)
      • 7.3.3.4 Thermoplastic copolyester elastomers (TPC-ET)
  • 7.4 OTHER MEDICAL ELASTOMERS

8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY

  • 8.1 INTRODUCTION
    • FIGURE 33 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    • TABLE 18 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 19 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
  • 8.2 EXTRUSION TUBING
    • 8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
  • 8.3 COMPRESSION MOLDING
    • 8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET
  • 8.4 INJECTION MOLDING
    • 8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET
  • 8.5 OTHER MANUFACTURING TECHNOLOGIES

9 MEDICAL POLYMER MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 34 MEDICAL INSTRUMENTS & DEVICES TO BE LARGEST APPLICATION OF MEDICAL POLYMER
    • TABLE 22 MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 23 MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 9.2 MEDICAL DISPOSABLES
    • 9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
    • 9.2.2 GLOVES
    • 9.2.3 SYRINGES
    • 9.2.4 MEDICAL BAGS
    • 9.2.5 OTHER MEDICAL DISPOSABLES
  • 9.3 MEDICAL INSTRUMENTS & DEVICES
    • 9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.3.2 MEDICAL TUBES
    • 9.3.3 CATHETERS
    • 9.3.4 DRUG DELIVERY
    • 9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES
  • 9.4 PROSTHETICS
    • 9.4.1 TECHNOLOGICAL DEVELOPMENTS TO DRIVE DEMAND
    • 9.4.2 IMPLANTS
    • 9.4.3 LIMB PROSTHESIS
    • 9.4.4 OTHER PROSTHETICS APPLICATIONS
  • 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS
    • 9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.5.2 DENTAL TOOLS
    • 9.5.3 SURGICAL INSTRUMENTS
    • 9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
  • 9.6 OTHER APPLICATIONS

10 MEDICAL POLYMER MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 35 MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 26 MEDICAL POLYMER MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 27 MEDICAL POLYMER MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2020-2023 (KILOTON)
    • TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2024-2029 (KILOTON)
  • 10.2 NORTH AMERICA
    • 10.2.1 IMPACT OF RECESSION ON NORTH AMERICA
    • FIGURE 36 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 30 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 31 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 42 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 43 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 44 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.2.2 US
      • 10.2.2.1 High R&D investments in medical sector to drive market growth
    • TABLE 46 US: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 47 US: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 50 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 51 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.2.3 CANADA
      • 10.2.3.1 Emerging demand for dental implants to drive market
    • TABLE 54 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 55 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.2.4 MEXICO
      • 10.2.4.1 Rising focus of manufacturers to expand manufacturing facilities to drive market growth
    • TABLE 62 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 63 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.3 ASIA PACIFIC
    • 10.3.1 RECESSION IMPACT
    • FIGURE 37 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 70 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 85 ASIA PACIFIC, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.3.2 CHINA
      • 10.3.2.1 Largest market for medical polymers in Asia Pacific
    • TABLE 86 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 87 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.3 INDIA
      • 10.3.3.1 Rapid economic growth and growing population to drive market growth
    • TABLE 94 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 95 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.4 SOUTH KOREA
      • 10.3.4.1 Advanced healthcare and medical technologies to propel market growth
    • TABLE 102 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 103 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.5 JAPAN
      • 10.3.5.1 Developments in minimally invasive treatment and robotic surgery to support market growth
    • TABLE 110 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 111 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.6 AUSTRALIA
      • 10.3.6.1 Regulatory compliance and strategic collaborations to support market growth
    • TABLE 118 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 119 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.7 REST OF ASIA PACIFIC
    • TABLE 126 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 127 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.4 EUROPE
    • 10.4.1 RECESSION IMPACT
    • FIGURE 38 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 134 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 135 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 136 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 137 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 138 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 139 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 140 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 141 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 142 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 143 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 144 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 145 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 146 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 147 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 148 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 149 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.4.2 GERMANY
      • 10.4.2.1 Rising demand in dental implant application to drive market
    • TABLE 150 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 151 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 152 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 153 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 154 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 155 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 156 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 157 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.3 FRANCE
      • 10.4.3.1 Aging population and sedentary lifestyle to drive demand
    • TABLE 158 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 159 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 160 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 161 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 162 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 163 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 164 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 165 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.4 UK
      • 10.4.4.1 Growing incidences of chronic diseases and government support for innovation to drive market
    • TABLE 166 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 167 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 168 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 169 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 170 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 171 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 172 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 173 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.5 ITALY
      • 10.4.5.1 Strong production facilities with presence of global players to propel market growth
    • TABLE 174 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 175 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 176 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 177 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 178 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 179 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 180 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 181 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.6 SPAIN
      • 10.4.6.1 Increase in government funding for healthcare sector to support market
    • TABLE 182 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 183 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 184 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 185 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 186 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 187 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 188 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 189 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.7 REST OF EUROPE
    • TABLE 190 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 191 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 192 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 193 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 194 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 195 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 196 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 197 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 RECESSION IMPACT
    • TABLE 198 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 199 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 200 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 201 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 202 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 203 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 205 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 206 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 207 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 208 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 209 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 210 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 212 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 213 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.5.2 SAUDI ARABIA
      • 10.5.2.1 Growing population and rise in aging population to drive market
    • TABLE 214 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 215 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 216 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 217 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 218 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 219 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 220 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 221 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.3 UAE
      • 10.5.3.1 Population growth and changing epidemiology expected to drive market growth
    • TABLE 222 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 223 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 224 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 225 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 226 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 227 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 228 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 229 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.4 SOUTH AFRICA
      • 10.5.4.1 NHI scheme, increased government spending on healthcare, and priority programs to propel market
    • TABLE 230 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 231 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 232 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 233 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 234 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 235 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 236 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 237 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.5 REST OF MIDDLE EAST & AFRICA
    • TABLE 238 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 239 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 240 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 241 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 242 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 243 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 244 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 245 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.6 SOUTH AMERICA
    • 10.6.1 RECESSION IMPACT
    • TABLE 246 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 247 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 248 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 249 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 250 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 251 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 252 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 253 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 254 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 255 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.6.2 BRAZIL
      • 10.6.2.1 Growing aging population, expanding economy, and increasing health awareness to drive market
    • TABLE 262 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 263 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 264 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 265 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 266 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 267 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 268 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 269 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.6.3 ARGENTINA
      • 10.6.3.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry
    • TABLE 270 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 271 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 272 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 273 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 274 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 275 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 276 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 277 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.6.4 REST OF SOUTH AMERICA
    • TABLE 278 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 279 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 280 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 281 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 282 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 283 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 284 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 285 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
    • FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2024
  • 11.3 MARKET SHARE ANALYSIS
    • 11.3.1 RANKING OF KEY MARKET PLAYERS, 2023
    • FIGURE 40 RANKING OF TOP FIVE PLAYERS IN MEDICAL POLYMER MARKET, 2023
    • 11.3.2 MARKET SHARE ANALYSIS OF KEY PLAYERS
    • TABLE 286 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION
    • FIGURE 41 MEDICAL POLYMER MARKET: SHARE OF KEY PLAYERS
      • 11.3.2.1 BASF SE
      • 11.3.2.2 SABIC
      • 11.3.2.3 Covestro AG
      • 11.3.2.4 Celanese Corporation
      • 11.3.2.5 Evonik Industries
  • 11.4 REVENUE ANALYSIS
    • FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2021-2024
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    • FIGURE 43 COMPANY VALUATION OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
    • FIGURE 44 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
  • 11.6 BRAND/PRODUCT COMPARISON
    • FIGURE 45 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • FIGURE 46 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX, 2023
    • 11.7.5 COMPANY FOOTPRINT
      • 11.7.5.1 Company overall footprint
      • 11.7.5.2 Company type footprint
      • 11.7.5.3 Company application footprint
      • 11.7.5.4 Company region footprint
  • 11.8 COMPANY EVALUATION MATRIX: START-UPS AND SMES
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • FIGURE 47 MEDICAL POLYMER MARKET: START-UPS/SMES EVALUATION MATRIX, 2023
    • 11.8.5 COMPETITIVE BENCHMARKING
    • TABLE 287 MEDICAL POLYMER MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 288 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 289 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, NOVEMBER 2021-MARCH 2024
    • 11.9.2 DEALS
    • TABLE 290 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021-MARCH 2024
    • 11.9.3 EXPANSIONS
    • TABLE 291 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021-MARCH 2024

12 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats) **
  • 12.1 MAJOR PLAYERS
    • 12.1.1 BASF SE
    • TABLE 292 BASF SE: COMPANY OVERVIEW
    • FIGURE 48 BASF SE: COMPANY SNAPSHOT
    • TABLE 293 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 294 BASF SE: DEALS, JANUARY 2021-MARCH 2024
    • 12.1.2 SABIC
    • TABLE 295 SABIC: COMPANY OVERVIEW
    • FIGURE 49 SABIC: COMPANY SNAPSHOT
    • TABLE 296 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 297 SABIC: DEALS, JANUARY 2021-MARCH 2024
    • 12.1.3 COVESTRO AG
    • TABLE 298 COVESTRO AG: COMPANY OVERVIEW
    • FIGURE 50 COVESTRO AG: COMPANY SNAPSHOT
    • TABLE 299 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 300 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 301 COVESTRO AG: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.4 CELANESE CORPORATION
    • TABLE 302 CELANESE CORPORATION: COMPANY OVERVIEW
    • FIGURE 51 CELANESE CORPORATION: COMPANY SNAPSHOT
    • TABLE 303 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 304 CELANESE CORPORATION: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 305 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.5 EVONIK INDUSTRIES
    • TABLE 306 EVONIK INDUSTRIES: COMPANY OVERVIEW
    • FIGURE 52 EVONIK INDUSTRIES: COMPANY SNAPSHOT
    • TABLE 307 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 308 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 309 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.6 ARKEMA
    • TABLE 310 ARKEMA: COMPANY OVERVIEW
    • FIGURE 53 ARKEMA: COMPANY SNAPSHOT
    • TABLE 311 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 312 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 313 ARKEMA: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.7 SOLVAY
    • TABLE 314 SOLVAY: COMPANY OVERVIEW
    • FIGURE 54 SOLVAY: COMPANY SNAPSHOT
    • TABLE 315 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.8 KURARAY CO., LTD.
    • TABLE 316 KURARAY CO., LTD.: COMPANY OVERVIEW
    • FIGURE 55 KURARAY CO., LTD.: COMPANY SNAPSHOT
    • TABLE 317 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 318 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC.
    • TABLE 319 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW
    • TABLE 320 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 321 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 322 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.10 DUPONT
    • TABLE 323 DUPONT: COMPANY OVERVIEW
    • FIGURE 56 DUPONT: COMPANY SNAPSHOT
    • TABLE 324 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 325 DUPONT: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 326 DUPONT: EXPANSIONS, JANUARY 2021-MARCH 2024
  • *Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 TRINSEO
    • TABLE 327 TRINSEO: COMPANY OVERVIEW
    • 12.2.2 KRATON CORPORATION
    • TABLE 328 KRATON CORPORATION: COMPANY OVERVIEW
    • 12.2.3 TOTAL PLASTICS
    • TABLE 329 TOTAL PLASTICS: COMPANY OVERVIEW
    • 12.2.4 SIMONA AMERICA
    • TABLE 330 SIMONA AMERICA: COMPANY OVERVIEW
    • 12.2.5 DSM
    • TABLE 331 DSM: COMPANY OVERVIEW
    • 12.2.6 INVIBIO
    • TABLE 332 INVIBIO: COMPANY OVERVIEW
    • 12.2.7 AVIENT CORPORATION
    • TABLE 333 AVIENT CORPORATION: COMPANY OVERVIEW
    • 12.2.8 RTP COMPANY
    • TABLE 334 RTP COMPANY: COMPANY OVERVIEW
    • 12.2.9 TEKNIPLEX
    • TABLE 335 TEKNIPLEX: COMPANY OVERVIEW
    • 12.2.10 TEKNOR APEX
    • TABLE 336 TEKNOR APEX: COMPANY OVERVIEW
    • 12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • TABLE 337 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW
    • 12.2.12 WACKER CHIMIE
    • TABLE 338 WACKER CHIMIE: COMPANY OVERVIEW
    • 12.2.13 HARDIE POLYMERS
    • TABLE 339 HARDIE POLYMERS: COMPANY OVERVIEW
    • 12.2.14 ELIX POLYMERS
    • TABLE 340 ELIX POLYMERS: COMPANY OVERVIEW
    • 12.2.15 INNOVATIVE POLYMER COMPOUNDS
    • TABLE 341 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS